Farida Mesli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Farida Mesli has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alain Luciani
AP-HP, Hôpitaux Universitaires Henri Mondor, Imagerie Médicale, Créteil, France
1 shared publication - Alexis Laurent
Technical University of Denmark
1 shared publication - Aurelien Amiot
Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, 94805, Villejuif, France; Department of Gastroenterology, University Hospital of Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin Bicêtre, France
1 shared publication - Aymeric Becq
Paris Est Créteil University, Gastroenterology department, APHP, Henri Mondor Hospital, Créteil, France
1 shared publication - Charlotte Gagniere
Department of Gastroenterology, Henri Mondor Hospital—APHP and Paris Est Creteil University, 1 Rue Gustave Eiffel, 94000 Creteil, France
1 shared publication - Christophe Duvoux
Medical Liver Transplant Unit, Hôpital Henri Mondor-APHP; Paris-Est Créteil University , France
1 shared publication
Latest Publications
- Open Access
- 11 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (4) , 1453
Long-Term Results of Endoscopic Metal Stenting for Biliary Anastomotic Stricture after Liver Transplantation
(1) Background: Anastomotic biliary stricture (ABS) is a well-known complication of liver transplantation which can lead to secondary biliary cirrhosis and graft dysfunction. The goal of this study was to evaluate the long-term outcomes of endoscopic metal stenting of ABS in the setting of deceased donor liver transplantation (DDLT). (2) Methods: Consecutive DDLT patients with endoscopic metal stenting for ABS between 2010 and 2015 were screened. Data on diagnosis, treatment and follow-up (until June 2022) were collected. The primary outcome was endoscopic treatment failure defined as the need for surgical refection. (3) Results: Among the 465 patients who underwent LT, 41 developed ABS. It was diagnosed after a mean period of 7.4 months (+/−10.6) following LT. Endoscopic treatment was technically successful in 95.1% of cases. The mean duration of endoscopic treatment was 12.8 months (+/−9.1) and 53.7% of patients completed a 1-year treatment. After a mean follow-up of 6.9 years (+/−2.3), endoscopic treatment failed in nine patients (22%) who required surgical refection. Conclusions: Endoscopic management with metal stenting of ABS after DDLT was technically successful in most cases, and half of the patients had at least one year of indwelling stent. Endoscopic treatment long-term failure rate occurred in one fifth of the patients.
- 11 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (4) , 1453
Open AccessLong-Term Results of Endoscopic Metal Stenting for Biliary Anastomotic Stricture after Liver Transplantation
(1) Background: Anastomotic biliary stricture (ABS) is a well-known complication of liver transplantation which can lead to secondary biliary cirrhosis and graft dysfunction. The goal of this study was to evaluate the long-term outcomes of endoscopic metal stenting of ABS in the setting of deceased donor liver transplantation (DDLT). (2) Methods: Consecutive DDLT patients with endoscopic metal stenting for ABS between 2010 and 2015 were screened. Data on diagnosis, treatment and follow-up (until June 2022) were collected. The primary outcome was endoscopic treatment failure defined as the need for surgical refection. (3) Results: Among the 465 patients who underwent LT, 41 developed ABS. It was diagnosed after a mean period of 7.4 months (+/−10.6) following LT. Endoscopic treatment was technically successful in 95.1% of cases. The mean duration of endoscopic treatment was 12.8 months (+/−9.1) and 53.7% of patients completed a 1-year treatment. After a mean follow-up of 6.9 years (+/−2.3), endoscopic treatment failed in nine patients (22%) who required surgical refection. Conclusions: Endoscopic management with metal stenting of ABS after DDLT was technically successful in most cases, and half of the patients had at least one year of indwelling stent. Endoscopic treatment long-term failure rate occurred in one fifth of the patients.